May 12 |
Skye Bioscience, Inc.'s (NASDAQ:SKYE) last week's 13% decline must have disappointed private equity firms who have a significant stake
|
May 10 |
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting
|
Apr 30 |
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting
|
Apr 23 |
Skye Bioscience to Present at Upcoming Investment Conferences
|
Apr 10 |
Skye Bioscience to uplist to Nasdaq Global Market
|
Apr 10 |
Skye Bioscience Uplists to The Nasdaq Global Market
|